Some cancer sufferers are spending large sums of money on expensive drugs that will not extend their life, a specialist says.
Professor Richard Sullivan, the director of the Institute of Cancer Policy at Kings College in London, has been in New Zealand for a conference. He said many of the most expensive cancer drugs simply did not do what they said they would. For example, some could shrink the cancer itself but do nothing to extend the life of the patient. "Some drugs are coming with enormous uncertainty about what sort of benefit they really deliver to patients ... but huge price tags. Read More